Q32 Bio Inc.

By person

28 insiders · 134 transactions

8.8×

Jodie Morrison holds 8.8 times base salary in stock. $5.68M of shares against $645.60K in salary for 2025.

Salary from the company's own proxy. The shares are what Jodie Morrison last reported holding, valued at $16.56, the price Common Stock was last bought or sold at on the open market here, on 25 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

5AM Ventures IV, L.P. entity

10% owner

—

$37.36M (14)

−$37.36M

6,903,511

$114.32M

+86.7%

PARMAR KUSH

Director

—

$37.36M (14)

−$37.36M

181,435

$3.00M

—

ORBIMED ADVISORS LLC entity

Director

$15.00M (2)

—

+$15.00M

625,000

$10.35M

—

Xu Diyong

Director

$15.00M (2)

—

+$15.00M

625,000

$10.35M

—

Temasek Holdings (Private) Ltd entity

10% owner

$10.00M (1)

—

+$10.00M

3,220,293

$53.33M

—

Vida Ventures, LLC entity

10% owner

$6.00M (1)

—

+$6.00M

770,845

$12.77M

—

Rock Springs Capital Management LP entity

10% owner

$4.00M (1)

—

+$4.00M

645,845

$10.70M

—

Flynn James E

10% owner

$32.00M (3)

$29.32M (13)

+$2.68M

4,087,305

$67.69M

—

TZIANABOS ARTHUR

Director

—

$2.07M (14)

−$2.07M

7,983

$132.20K

−88.3%

Seymour Albert

See Remarks

—

$1.66M (16)

−$1.66M

150,874

$2.50M

−36.3%

Smith W Bradford

See remarks

—

$1.27M (13) scheduled

−$1.27M

14,219

$235.47K

—

Rasty Siyamak

Chief Operating Officer

—

$321.78K (2)

−$321.78K

222,707

$3.69M

−6.7%

Morrison Jodie Pope

CEO

—

$304.48K (4)

−$304.48K

343,259

$5.68M

—

Kelly Timothy P

Chief Operating Officer

—

$249.86K (10) scheduled

−$249.86K

2,224

$36.83K

—

Kalowski Lee

CFO and President

—

$122.84K (4)

−$122.84K

138,471

$2.29M

—

Violette Shelia M.

Chief Scientific Officer

—

$64.43K (3)

−$64.43K

127,771

$2.12M

—

Alloway Paul

See Remarks

—

$30.77K (4)

−$30.77K

51,566

$853.93K

+140.3%

Cohn Gabriel

Chief Medical Officer

—

$6.28K (1)

−$6.28K

2,629

$43.54K

—

Blum Michael Lee

Chief Commercial Officer

—

$3.41K (1)

−$3.41K

13,538

$224.19K

+61.1%

Michaud Charles Jr

See Remarks

—

$2.79K (2)

−$2.79K

18,046

$298.84K

+97.4%

Jordan Julie

Chief Medical Officer

—

$2.71K (4) scheduled

−$2.71K

7,496

$124.13K

+197.6%

ARCH Venture Fund VIII, L.P. entity

10% owner

—

11,837,389

$196.03M

+95.1%

GILLIS STEVEN

Director

—

6,068,695

$100.50M

—

Novartis Institutes for BioMedical Research, Inc. entity

10% owner

—

1,979,226

$32.78M

—

SHAH MAHENDRA

Director

—

1,159,742

$19.21M

—

Manke Isaac

Director

—

53,521

$886.31K

—

Campagna Jason

Chief Medical Officer

—

37,500

$621.00K

—

Gregory Richard J.

Director

—

10,806

$178.95K

—

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 12,180,701 to 29,769,466 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

By person

Individual transactions

What was left out